从欧洲心脏病学会指南更新看心脏再同步治疗适应证的变迁
被引量：1
Understanding the changes of indications of cardiac resynchronization therapy based on 2010 focused update of ESC guidelines on device therapy in heart failure
摘要
心脏再同步治疗（cardiac resvnchronization therapy．CRT）作为慢性心力衰竭（HF）的一种非药物治疗策略，其临床疗效已得到充分肯定。尤其对于心功能Ⅲ或Ⅳ级（NYHA分级）、左心室射血分数（LVEF）≤0．35、体表心电图QRS时限≥120I／IS和经优化药物治疗的窦性心律心力衰竭患者，CRT可以逆转心室重构，提高LVEF，改善患者生活质量，并且能降低因心力衰竭所导致的住院率。
出处
《中华心律失常学杂志》
2011年第2期115-118,共4页
Chinese Journal of Cardiac Arrhythmias
基金
国家自然科学基金（30900604,81070266）
参考文献25
-
1Vardas PE, Auricchio A, Blanc JJ,et al. European practice guide- lines on cardiac pacemakers and cardiac resyncbronization therapy. Working Group of the European Society of Cardiology ( ESC ) on cardiac pacemakers and cardiac resynchronization therapy. Devel- oped in collaboration with the European Heart Rhythm Associa- tion. Rev Esp Cardio1,2007,60 : 1272 e1-1272 e51.
-
2Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC ( HFA ) and endorsed by the European Society of Intensive Care Medicine ( ESIC M ). Eur Heart J, 2008,29 : 2388-2442.
-
3Moss A J, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med, 2009,361 : 1329-1338.
-
4Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coil Cardiol, 2008,52 : 1834- 1843.
-
5Gregoratos G, Abrams J, Epstein AE, et al, ACC/AHAZNASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices:summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines( ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines ). J Cardiovasc Electrophysiol, 2002, 13 : 1183-1199.
-
6Hunt SA, ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult : a report of the American College of Cardiology/American Heart Association Task Force on Praetiee Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coil Cardiol,2005,46 : e1-82.
-
7Epstein AE, DiMarco JP, Ellenbogen KA, et al, ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Ab- normalities : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Up- date for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coil Cardio1,2008,51 : e1-62.
-
8Krum H. The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure : full text ( up- date 2005 ). Eur Heart J ,2005,26:2472 ; author reply 2473-2474.
-
9Wikstrom G. , Blomstrtim-Lundqvist C, Andren B, et al, The effects of aetiology on outcome in patients treated with cardiac resynchro- nization therapy in the CARE-HF trial. Eur Heart J ,2009,30:782- 788.
-
10Higgins SL, Hummel JD, Niazi IK, et al. , Cardiac resynchroniza- tion therapy for the treatment of heart failure in patients with in- traventricular conduction delay and malignant ventricular tachya- rrhythmias. J Am Coil Cardiol,2003,42 : 1454-1459.
同被引文献7
-
1王冬梅,王祖禄,韩雅玲,臧红云,周薇薇,曹荣,荆全民,王守力.充血性心力衰竭伴慢性心房颤动房室结消融及双心室同步起搏治疗半年疗效观察[J].中华心律失常学杂志,2004,8(6):383-384. 被引量：9
-
2Bueno H,Ross JS,Wang Y,et al. Trends in length of stay and short-term outcomes among medicare patients hospitalized for heart failure, 1993-2006. JAMA, 2010,303 : 2141-2147.
-
3Borleffs CJ, van Welsenes GH, van Bommel RJ, et al. Mortality risk score in primary prevention implantable cardiovener defib- rillator recipients with non-ischaemic or ischaemic heart dis- ease. Eur Heart J,2010,31:712-718.
-
4Soliman OI, van Dalen BM, Nemes A, et al. Quantification of left ventricular systolic dyssynchrony by real-time three-di- mensional echocardiography. J Am Soc Echocardiogr, 2009,22 232-239.
-
5Chung ES,Leon AR,Tavazzi L,et al. Results of the predictors of response to CRT(PROSPECT)trial. Circulation, 2008,117: 2608-2616.
-
6郑刚.心力衰竭防治及管理任重道远[J].中华老年心脑血管病杂志,2011,13(1):2-3. 被引量：3
-
7高敬,华琦,王彩荣,李晓辉,高承梅.实时三维超声心动图定量评价心力衰竭患者左心室收缩同步性[J].中华老年心脑血管病杂志,2011,13(1):6-9. 被引量：8
二级引证文献3
-
1杨燕,苗云波,周燕,李平仙,张静.12例老年难治性慢性心力衰竭患者心脏再同步加自动复律治疗的疗效观察[J].中华老年心脑血管病杂志,2013,15(3):319-320. 被引量：2
-
2牛振山.慢性心力衰竭CRT治疗中不同部位左心室起搏的效果比较[J].实用心脑肺血管病杂志,2016,24(B04):75-75.
-
3李楠,陈瑛.厄贝沙坦联合美托洛尔治疗慢性充血性心力衰竭的疗效观察[J].中国基层医药,2017,24(17):2639-2643. 被引量：7
-
1朱海燕,沈洪.欧洲心脏病学会指南(五) 生活方式的建议[J].中国危重病急救医学,2004,16(1):63-64. 被引量：7
-
2朱海燕,沈洪.欧洲心脏病学会指南(四)院内后期治疗过程[J].中国危重病急救医学,2003,15(12):766-767. 被引量：6
-
3梁艺,唐建华,黄学成,尚晓斌,王琦武.冠心病患者降脂药物的有效应用研究[J].中国民族民间医药,2009,18(16):88-88. 被引量：2
-
4张维,沈洪.欧洲心脏病学会指南(三):经皮冠状动脉介入疗法(续二)[J].中国危重病急救医学,2003,15(11):668-668.
-
5张维,沈洪.欧洲心脏病学会指南(二)院前及急诊处理:恢复冠脉血流及心肌组织再灌注[J].中国危重病急救医学,2003,15(6):376-377. 被引量：6
-
6张维.欧洲心脏病学会指南(一) ST段抬高的急性心肌梗死患者处理原则[J].中国危重病急救医学,2003,15(5):317-318. 被引量：4
-
7金奇,吴立群.心脏再同步治疗在轻微和无症状心力衰竭患者中的临床应用[J].中华心律失常学杂志,2010,14(3):184-186.
-
8张艳玲,谭小颖,杨镇军.比索洛尔治疗80岁以上慢性心力衰竭患者的疗效观察[J].中国实用医刊,2012,39(10):31-32.
-
9刘新文,唐明辉,叶青,张华.对扩张型心肌病进行优化药物治疗的疗效分析[J].求医问药（下半月刊）,2012,10(3):127-127.
-
10郭苗,刘燕妮.稳定性心绞痛患者的优化药物治疗研究[J].大家健康（学术版）,2014(3):138-138.
